Fig. 1From: Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progressiona Targeted genomic variants in each patient by category. Per patient summary of b SNVs, c SVs and d small indels targeted and detected in any ctDNA sample by deep targeted sequencingBack to article page